Major Statin Meta-Analysis Finds Fewer Side Effects, But Transparency Questions Remain
One of the largest reviews of statin trials to date suggests most reported symptoms aren’t caused by the drugs. Some researchers say restricted data access and industry funding still complicate efforts to independently assess harms
Feb 19, 2026